Global Biologic Drugs Market Research Report 2018

July 2018 | 91 pages | ID: GBBF7F69D19EN
QYResearch

Abstracts

This report studies the global Biologic Drugs market status and forecast, categorizes the global Biologic Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Biologic Drugs market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

• Roche
• Abbott Laboratories
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Amgen
• Sanofi
• Novartis
• Eli Lilly
• Amgen

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Humira
• Remicade
• Rituxan
• Enbrel
• Lantus
• Avastin
• Herceptin
• Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Diabetes
• Inflammation
• Auto-Immune Diseases
• Blood Diseases
• Cardiovascular Diseases
• Others

The study objectives of this report are:

• To analyze and study the global Biologic Drugs sales, value, status (2013-2017) and forecast (2018-2025).
• Focuses on the key Biologic Drugs manufacturers, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologic Drugs are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Biologic Drugs Manufacturers
Biologic Drugs Distributors/Traders/Wholesalers
Biologic Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations

• With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
• Regional and country-level analysis of the Biologic Drugs market, by end-use.
• Detailed analysis and profiles of additional market players.

Contents

Global Biologic Drugs Market Research Report 2018

1 BIOLOGIC DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologic Drugs
1.2 Biologic Drugs Segment by Type (Product Category)
  1.2.1 Global Biologic Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Biologic Drugs Production Market Share by Type (Product Category) in 2017
  1.2.3 Humira
  1.2.4 Remicade
  1.2.5 Rituxan
  1.2.6 Enbrel
  1.2.7 Lantus
  1.2.8 Avastin
  1.2.9 Herceptin
  1.2.10 Others
1.3 Global Biologic Drugs Segment by Application
  1.3.1 Biologic Drugs Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Diabetes
  1.3.3 Inflammation
  1.3.4 Auto-Immune Diseases
  1.3.5 Blood Diseases
  1.3.6 Cardiovascular Diseases
  1.3.7 Others
1.4 Global Biologic Drugs Market by Region (2013-2025)
  1.4.1 Global Biologic Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Biologic Drugs (2013-2025)
  1.5.1 Global Biologic Drugs Revenue Status and Outlook (2013-2025)
  1.5.2 Global Biologic Drugs Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL BIOLOGIC DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Biologic Drugs Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Biologic Drugs Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Biologic Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Biologic Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Biologic Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Biologic Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biologic Drugs Market Competitive Situation and Trends
  2.5.1 Biologic Drugs Market Concentration Rate
  2.5.2 Biologic Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL BIOLOGIC DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Biologic Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Biologic Drugs Production and Market Share by Region (2013-2018)
3.3 Global Biologic Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL BIOLOGIC DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Biologic Drugs Consumption by Region (2013-2018)
4.2 North America Biologic Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Biologic Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Biologic Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Biologic Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Biologic Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Biologic Drugs Production, Consumption, Export, Import (2013-2018)

5 GLOBAL BIOLOGIC DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Biologic Drugs Production and Market Share by Type (2013-2018)
5.2 Global Biologic Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Biologic Drugs Price by Type (2013-2018)
5.4 Global Biologic Drugs Production Growth by Type (2013-2018)

6 GLOBAL BIOLOGIC DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Biologic Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Biologic Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL BIOLOGIC DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Roche
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Biologic Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Roche Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Abbott Laboratories
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Biologic Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Abbott Laboratories Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Johnson & Johnson
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Biologic Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Johnson & Johnson Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Merck & Co.
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Biologic Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Merck & Co. Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Biologic Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Pfizer Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
  7.5.4 Main Business/Business Overview
7.6 Amgen
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Biologic Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Amgen Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Sanofi
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Biologic Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Sanofi Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Novartis
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Biologic Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Novartis Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Eli Lilly
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Biologic Drugs Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Eli Lilly Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Amgen
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Biologic Drugs Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Amgen Biologic Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
  7.10.4 Main Business/Business Overview

8 BIOLOGIC DRUGS MANUFACTURING COST ANALYSIS

8.1 Biologic Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biologic Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Biologic Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biologic Drugs Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL BIOLOGIC DRUGS MARKET FORECAST (2018-2025)

12.1 Global Biologic Drugs Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Biologic Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Biologic Drugs Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Biologic Drugs Price and Trend Forecast (2018-2025)
12.2 Global Biologic Drugs Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Biologic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Biologic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Biologic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Biologic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Biologic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Biologic Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Biologic Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Biologic Drugs Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biologic Drugs
Figure Global Biologic Drugs Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Biologic Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Humira
Table Major Manufacturers of Humira
Figure Product Picture of Remicade
Table Major Manufacturers of Remicade
Figure Product Picture of Rituxan
Table Major Manufacturers of Rituxan
Figure Product Picture of Enbrel
Table Major Manufacturers of Enbrel
Figure Product Picture of Lantus
Table Major Manufacturers of Lantus
Figure Product Picture of Avastin
Table Major Manufacturers of Avastin
Figure Product Picture of Herceptin
Table Major Manufacturers of Herceptin
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Biologic Drugs Consumption (K Units) by Applications (2013-2025)
Figure Global Biologic Drugs Consumption Market Share by Applications in 2017
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Inflammation Examples
Table Key Downstream Customer in Inflammation
Figure Auto-Immune Diseases Examples
Table Key Downstream Customer in Auto-Immune Diseases
Figure Blood Diseases Examples
Table Key Downstream Customer in Blood Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Biologic Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Biologic Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Biologic Drugs Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Biologic Drugs Major Players Product Capacity (K Units) (2013-2018)
Table Global Biologic Drugs Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Biologic Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Biologic Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Biologic Drugs Capacity (K Units) of Key Manufacturers in 2018
Figure Global Biologic Drugs Major Players Product Production (K Units) (2013-2018)
Table Global Biologic Drugs Production (K Units) of Key Manufacturers (2013-2018)
Table Global Biologic Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Biologic Drugs Production Share by Manufacturers
Figure 2017 Biologic Drugs Production Share by Manufacturers
Figure Global Biologic Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Biologic Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Biologic Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Biologic Drugs Revenue Share by Manufacturers
Table 2018 Global Biologic Drugs Revenue Share by Manufacturers
Table Global Market Biologic Drugs Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Biologic Drugs Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Biologic Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologic Drugs Product Category
Figure Biologic Drugs Market Share of Top 3 Manufacturers
Figure Biologic Drugs Market Share of Top 5 Manufacturers
Table Global Biologic Drugs Capacity (K Units) by Region (2013-2018)
Figure Global Biologic Drugs Capacity Market Share by Region (2013-2018)
Figure Global Biologic Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Biologic Drugs Capacity Market Share by Region
Table Global Biologic Drugs Production by Region (2013-2018)
Figure Global Biologic Drugs Production (K Units) by Region (2013-2018)
Figure Global Biologic Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Biologic Drugs Production Market Share by Region
Table Global Biologic Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Biologic Drugs Revenue Market Share by Region (2013-2018)
Figure Global Biologic Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Biologic Drugs Revenue Market Share by Region
Figure Global Biologic Drugs Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Biologic Drugs Consumption (K Units) Market by Region (2013-2018)
Table Global Biologic Drugs Consumption Market Share by Region (2013-2018)
Figure Global Biologic Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Biologic Drugs Consumption (K Units) Market Share by Region
Table North America Biologic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Biologic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Biologic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Biologic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Biologic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Biologic Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Biologic Drugs Production (K Units) by Type (2013-2018)
Table Global Biologic Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Biologic Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Biologic Drugs by Type
Table Global Biologic Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Biologic Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Biologic Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Biologic Drugs by Type
Table Global Biologic Drugs Price (USD/Unit) by Type (2013-2018)
Figure Global Biologic Drugs Production Growth by Type (2013-2018)
Table Global Biologic Drugs Consumption (K Units) by Application (2013-2018)
Table Global Biologic Drugs Consumption Market Share by Application (2013-2018)
Figure Global Biologic Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Biologic Drugs Consumption Market Share by Application in 2017
Table Global Biologic Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Biologic Drugs Consumption Growth Rate by Application (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (Roche) and Gross Margin (2013-2018)
Figure Roche Biologic Drugs Production Growth Rate (2013-2018)
Figure Roche Biologic Drugs Production Market Share (2013-2018)
Figure Roche Biologic Drugs Revenue Market Share (2013-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Laboratories Biologic Drugs Production Growth Rate (2013-2018)
Figure Abbott Laboratories Biologic Drugs Production Market Share (2013-2018)
Figure Abbott Laboratories Biologic Drugs Revenue Market Share (2013-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologic Drugs Production Growth Rate (2013-2018)
Figure Johnson & Johnson Biologic Drugs Production Market Share (2013-2018)
Figure Johnson & Johnson Biologic Drugs Revenue Market Share (2013-2018)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co. Biologic Drugs Production Growth Rate (2013-2018)
Figure Merck & Co. Biologic Drugs Production Market Share (2013-2018)
Figure Merck & Co. Biologic Drugs Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Biologic Drugs Production Growth Rate (2013-2018)
Figure Pfizer Biologic Drugs Production Market Share (2013-2018)
Figure Pfizer Biologic Drugs Revenue Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologic Drugs Production Growth Rate (2013-2018)
Figure Amgen Biologic Drugs Production Market Share (2013-2018)
Figure Amgen Biologic Drugs Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologic Drugs Production Growth Rate (2013-2018)
Figure Sanofi Biologic Drugs Production Market Share (2013-2018)
Figure Sanofi Biologic Drugs Revenue Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologic Drugs Production Growth Rate (2013-2018)
Figure Novartis Biologic Drugs Production Market Share (2013-2018)
Figure Novartis Biologic Drugs Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Biologic Drugs Production Growth Rate (2013-2018)
Figure Eli Lilly Biologic Drugs Production Market Share (2013-2018)
Figure Eli Lilly Biologic Drugs Revenue Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Biologic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologic Drugs Production Growth Rate (2013-2018)
Figure Amgen Biologic Drugs Production Market Share (2013-2018)
Figure Amgen Biologic Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologic Drugs
Figure Manufacturing Process Analysis of Biologic Drugs
Figure Biologic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Biologic Drugs Major Manufacturers in 2017
Table Major Buyers of Biologic Drugs
Table Distributors/Traders List
Figure Global Biologic Drugs Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Biologic Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Biologic Drugs Production (K Units) Forecast by Region (2018-2025)
Figure Global Biologic Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Biologic Drugs Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Biologic Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Biologic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Biologic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Biologic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Biologic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Biologic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Biologic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Biologic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Biologic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Biologic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Biologic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Biologic Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Biologic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Biologic Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Biologic Drugs Production (K Units) Forecast by Type (2018-2025)
Figure Global Biologic Drugs Production (K Units) Forecast by Type (2018-2025)
Table Global Biologic Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Biologic Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Biologic Drugs Price Forecast by Type (2018-2025)
Table Global Biologic Drugs Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Biologic Drugs Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source